Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.
2.

Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.

Wartenberg M, Hoffmann E, Schwindt H, Grünheck F, Petros J, Arnold JR, Hescheler J, Sauer H.

FEBS Lett. 2005 Aug 15;579(20):4541-4549.

3.

Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.

Jung SN, Yang WK, Kim J, Kim HS, Kim EJ, Yun H, Park H, Kim SS, Choe W, Kang I, Ha J.

Carcinogenesis. 2008 Apr;29(4):713-21. doi: 10.1093/carcin/bgn032. Epub 2008 Feb 6.

PMID:
18258605
4.

Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis.

Yang J, Li H, Chen YY, Wang XJ, Shi GY, Hu QS, Kang XL, Lu Y, Tang XM, Guo QS, Yi J.

Free Radic Biol Med. 2004 Dec 15;37(12):2027-41.

PMID:
15544921
5.

Emodin has cytotoxic and protective effects in rat C6 glioma cells: roles of Mdr1a and nuclear factor kappaB in cell survival.

Kuo TC, Yang JS, Lin MW, Hsu SC, Lin JJ, Lin HJ, Hsia TC, Liao CL, Yang MD, Fan MJ, Wood WG, Chung JG.

J Pharmacol Exp Ther. 2009 Sep;330(3):736-44. doi: 10.1124/jpet.109.153007. Epub 2009 Jun 23.

7.
8.
9.

Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.

Cheema SK, Gobin AS, Rhea R, Lopez-Berestein G, Newman RA, Mathur AB.

Int J Pharm. 2007 Aug 16;341(1-2):221-9. Epub 2007 Apr 3.

PMID:
17499461
10.

Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.

Minelli A, Bellezza I, Tucci A, Rambotti MG, Conte C, Culig Z.

Prostate. 2009 Apr 1;69(5):538-47. doi: 10.1002/pros.20900.

PMID:
19107848
11.

Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.

Martínez-Sánchez G, Giuliani A.

J Exp Clin Cancer Res. 2007 Mar;26(1):39-50. Review.

PMID:
17550131
12.

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.

Sullivan R, Paré GC, Frederiksen LJ, Semenza GL, Graham CH.

Mol Cancer Ther. 2008 Jul;7(7):1961-73. doi: 10.1158/1535-7163.MCT-08-0198.

13.

Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation.

Wang W, Sun YP, Huang XZ, He M, Chen YY, Shi GY, Li H, Yi J, Wang J.

Biochem Pharmacol. 2010 Apr 15;79(8):1134-40. doi: 10.1016/j.bcp.2009.12.006. Epub 2009 Dec 11.

PMID:
20005210
14.

Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.

Reddy KR, Guan Y, Qin G, Zhou Z, Jing N.

Prostate. 2011 Dec;71(16):1796-809. doi: 10.1002/pros.21397. Epub 2011 Apr 7.

PMID:
21480310
15.

Reactive oxygen species and HIF-1 signalling in cancer.

Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R.

Cancer Lett. 2008 Jul 18;266(1):12-20. doi: 10.1016/j.canlet.2008.02.028. Epub 2008 Apr 18. Review.

PMID:
18378391
16.

Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.

Wang W, Sun Y, Li X, Li H, Chen Y, Tian Y, Yi J, Wang J.

Oncol Rep. 2011 Nov;26(5):1143-8. doi: 10.3892/or.2011.1390. Epub 2011 Jul 14.

PMID:
21769433
17.

Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.

Choi KJ, Piao YJ, Lim MJ, Kim JH, Ha J, Choe W, Kim SS.

Cancer Res. 2007 Apr 15;67(8):3654-62.

18.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
19.

Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.

Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B.

Pharmazie. 2008 Jul;63(7):528-33.

PMID:
18717489
20.

Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.

Li X, Wang H, Wang J, Chen Y, Yin X, Shi G, Li H, Hu Z, Liang X.

BMC Cancer. 2016 Aug 2;16:578. doi: 10.1186/s12885-016-2640-3.

Supplemental Content

Support Center